Agenda
(subject to change) 
 

Wednesday, April 26

   

7:00 am -- 11:00 am

CMCN Certification Exam
Additional fee applies. Eligibility and application must be approved by April 1, 2017. For more information, please email or call with questions asnyder@abmcn.org or 804-527-1905

 

10:30 am -- 7:30 pm

Pre-Registration  
11:00am -- 5:00pm Exhibitor Hall Set Up  
     

Thursday, April 27

   
7:45am -- 8:45am Keynote: The Future of Healthcare Delivery
I. Steven Udvarhelyi, MD,
President and CEO, Blue Cross and Blue Shield of Louisiana
 
8:45am-9:30am Break in Exhibit Hall
 
   
 


BUSINESS TRACK SESSION
 


POPULATION HEALTH MANAGEMENT
  


ONCOLOGY
9:30am -- 10:30am Value-Based Care: Is this the New Reality and Are You Ready?
Jeffrey Harrison, PhD, MBA, MHA, FACHE, Professor and Chair, Department of Public Health, University of North Florida and Debra Harrison, DNP, RN, NEW-BC, Vice President, Clinical Analytics, AMR Inc and Chief Nursing Officer Emeritus, Mayo Clinic Florida
Novel Therapeutic Options for the Optimal Management of Inflammatory Bowel Disease
Joel Pekow, MD, Assistant Professor of Medicine, Section of Gastroenterology, University of Chicago

Understanding Appropriate Treatment Options to Prevent and Manage Chemotherapy-Induced Nausea and Vomiting (CINV)
Aminah Jatoi, MD, Professor, Department of Oncology, Mayo Clinic

10:30am-11:30am Data Analytics is a Mandatory Components of the Evolving Healthcare Ecosystem
Lawrence Schimmel, MD, FACS, Chief Medical Officer, Qualmetrix
Exploring New Advances in Current & Novel Treatments for the Management of Epilepsy
Dennis Dlugos, MD, Professor of Neurology & Pediatrics, The Children’s Hospital of Philadelphia

Navigating a Complex Treatment Landscape in Advanced NSCLC: Individualizing Therapy for Improved Patient Outcomes
Mark Socinski, MD, Executive Medical Director, Thoracic Oncology Program, Florida Hospital Cancer Institute

11:30am-12:30pm Lunch in Exhibit Hall Lunch in Exhibit Hall Lunch in Exhibit Hall
12:30pm-1:30pm Roadmap to Successful Capitation and Risk Contracting Arrangements
Joseph Slater FSA, MAAA, Partner and Consulting Actuary, Axene Health Partners
What's New in the Evolving Treatment Landscape for Moderate-to-Severe Atopic Dermatitis (AD)
Adelaide Hebert, MD, Professor of Dermatology & Pediatrics, University of Texas Medical School-Houston
Updates in the Management of Hormone Receptor-Positive (HR+) Advanced Breast Cancer
Adam Brufsky, MD, PhD, FACP, Professor of Medicine & Associate Division Chief, Hematology/Oncology, University of Pittsburgh School of Medicine
1:30pm-2:30pm Optimizing Processes to Create a Successful Comprehensive Care for Joint Replacement with Exceptional Clinical and Financial Outcomes: A Case Study
Thomas Morrow, MD, Physician Consultant
What's New in CFTR Modulator Therapy in the Management of Cystic Fibrosis
Christian Merlo, MD, MPH, Assistant Professor of Medicine & Epidemiology, Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine
New Frontiers in Metastatic Melanoma: A Closer Look at the Role of Immunotherapy
Philip Friedlander, MD, Assistant Professor of Medicine, Hematology & Oncology, Icahn School of Medicine, Mount Sinai
2:30pm-3:00pm Break in Exhibit Hall Break in Exhibit Hall

Break in Exhibit Hall

3:00pm-4:00pm Getting to Population Health: Learning from Success
Kimberly White, Vice President, Numerof & Associates
Improving Patient Outcomes with Novel Treatments and Strategies in the Management of Relapsing Multiple Sclerosis
Gary Owens, MD, President, Gary Owens Associates

Managing Castration-Resistant Prostate Cancer: Understanding the Therapeutic Landscape
Michael Hurwitz, MD, PhD, Assistant Professor of Medicine, Section of Medical Oncology, Yale Comprehensive Cancer Center

4:00pm-5:00pm Lessons Learned from: America's Most Successful Physician Owned ACO: A PBACO Case Study
Hymin Zucker, MD, Founding Chief Medical Officer, Rebecca Prostko, MD, Executive Committee Chairperson, and David Klebonis, Chief Operating Officer, Palm Beach Accountable Care Organization, LLC
Exploring the Role of PCSK9 Inhibitors in the Reduction of LDL-C in Patients with Dyslipidemia
Michael Miller, MD, FACC, FAHA, Professor of Cardiovascular Medicine, Epidemiology & Public Health, University of Maryland School of Medicine

Novel Treatment Advances and Approaches in the Management of Relapsed/Refractory Multiple Myeloma
Ravi Vij, MD Associate Professor of Medicine, Division of Medical Oncology, Washington University School of Medicine

5:00pm-6:30pm

Reception in Exhibit Hall Reception in Exhibit Hall

Reception in Exhibit Hall

     
Friday, April 28  
7:00am -- 7:30am Breakfast in Exhibit Hall  
7:45am -- 8:45am Keynote: Managed Care Contracting Strategies:
Planning for Value-Based Arrangements

David Gregory, Principal, Healthcare Consulting Practice Leader,
and
Michael Patti, Principal, Baker Tilly Virchow Krause
8:45am-9:30am Break in Exhibit Hall
 
 


BUSINESS TRACK SESSION
 


POPULATION HEALTH MANAGEMENT
  


ONCOLOGY
9:30am -- 10:30am Tackling the Complexities of Value-Based Physician Compensation
Karin Chernoff Kaplan, MBA, CVA, Director, Veralon
Real-world Insights & Economic Considerations in Type 2 Diabetes: The Challenge of Sustaining Glycemic Control & Medication Adherence Over Time (not accredited)
James Gavin, III, MD, MACP, Professor of Medicine, Emory University and Indiana School of Medicine and Kate Fitch, Principal, Healthcare Management Consultant, Milliman
Novel Therapies in the Management of Advanced Renal Cell Carcinoma
(RCC): New Strategies and Options for Improved Patient Outcomes
M. Dror Michaelson, MD, PhD, Associate Professor of Medicine, Clinical Director, Urologic Oncology, Massachusetts General Hospital Cancer Center
10:30am -- 11:30am Next Gen HIT and Value-Based Care for Very Complex Populations
Jayresa Sass, Behavioral Intervention Specialist, Services for the UnderServed (SUS) and
Donna Lichti, RN, Senior Clinical Director, Virtual Health
Improving Management Strategies and Patient Adherence in the Treatment of Psoriasis
Steven Feldman, MD, PhD, Department of Dermatology, Wake Forest University School of Medicine
Perspective of the Self- Funded Employer on Oncology
Karen van Caulil, PhD, President and CEO, Florida Health Care Coalition
11:30am-12:30pm Lunch in Exhibit Hall
 
Lunch in Exhibit Hall Lunch in Exhibit Hall
 


POPULATION HEALTH
MANAGEMENT II

 


POPULATION HEALTH MANAGEMENT  


GENOMICS BIOTECH AND EMERGING MEDICAL TECHNOLOGIES
12:30pm-1:30pm Controlling Severe Asthma though Advanced Diagnosis and Treatment Strategies
Jim Donahue, MD, Professor, University of North Carolina Pulmonary/Critical Care
Effective Strategies and Clinical Updates in Pulmonary Arterial Hypertension
Harrison Farber, MD, Boston Medical Center, Boston University
Recent Barriers and Future Insights of Biosimilars
Steven Feldman, MD, PhD, Department of Dermatology, Wake Forest University School of Medicine
1:30pm-2:30pm Improving Diagnosis and Treatment Strategies of Major Depressive Disorder
Leslie Citrome, MD, MPH, Clinical Professor of Psychiatry & Behavioral Sciences, New York Medical College
Preventing Acute Exacerbations through Novel Insights in Treatment Strategies for COPD
Jim Donahue, MD, Professor, University of North Carolina Pulmonary/Critical Care
Effective Strategies and Clinical Updates in Rheumatoid Arthritis
Gary Owens, MD, President, Gary Owens Associates
2:30pm-2:45pm Break Break Break
2:45pm-3:45pm Advanced Insights into the Prevention, Treatment and Management of Alzheimer's Disease
Naushira Pandya, MD, CMD, FACP, Professor & Chair, Department of Geriatrics, Director Geriatrics Education Center, Nova Southeastern University College of Osteopathic Medicine
Individualizing Treatment in the Management of Type 2 Diabetes Novel Therapies for Improved Patient Outcomes
Richard Pratley, MD, Director, Florida Hospital Diabetes Institute
 
New Horizons in the Diagnosis and Management of Idiopathic Pulmonary Fibrosis (IPF)
Leann Silhan, MD, Assistant Professor, Division of Pulmonary & Critical Care Medicine, Department of Medicine, Johns Hopkins University School of Medicine
3:45pm-4:45pm   Optimizing Patient Outcomes in the Management of HIV/AIDS
Anne Monroe, MD, MSPH, Assistant Professor of Medicine, Johns Hopkins University School of Medicine
Evolving Considerations in the Individualization of Treatment in Metastatic Colorectal Cancer (mCRC): What do Targeted Therapies have to Offer?
Minsig, Choi, MD, Director of Outpatient Oncology, Co-leader Colorectal MDT, Associate Professor of Medicine, Stony Brook University
 

Agenda is subject to change